Hormonal
Intermittent Fasting (IF) regimens (5:2, ADF, ADMF, TRF) produce weight loss comparable to daily caloric restriction (CR), but may offer superior insulin-sensitizing benefits independent of weight loss.
If you are choosing between Intermittent Fasting and daily calorie restriction for weight loss, know that both methods are equally effective for losing weight. However, IF may offer extra benefits for your metabolic health, such as better insulin sensitivity, which might be important if you have prediabetes or metabolic syndrome. Choose the method you can sustain long-term.
Weight loss is common after IF but does not appear to be different than daily caloric restriction when compared directly. IF may also provide additional cardiometabolic benefit, such as insulin sensitization, that is independent from weight loss.
Why this rating
Based on a comprehensive review of multiple clinical trials and meta-analyses.
Source
Intermittent Fasting and Metabolic Health: From Religious Fast to Time‐Restricted Feeding
Kristin K. Hoddy et al. · Obesity · 2020
DOI 10.1002/oby.22829
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →